SLN vs AVLN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SLN · Silence Therapeutics$19.81 ▲ 0.00%
AVLN · Avalyn Pharma$28.40 ▼ 1.05%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SLN +171.0%
- AVLN -3.7%
Head to head
| Metric | SLN | AVLN |
|---|---|---|
| Price | $19.81 | $28.40 |
| Change today | ▲ 0.00% | ▼ 1.05% |
| Market cap | $1.23B | $1.26B |
| Return, 3 months | +49.1% | -24.6% |
| Return, year to date | +225.8% | – |
| Return, 1 year | +213.9% | – |
| P/E (TTM) | – | – |
| P/B | -5.7 | 3.4 |
| P/E percentile vs own 5y | 0th | 74th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -100.0% | – |
| Net profit growth (YoY) | +40.7% | -43.3% |
| Gross margin | 95.0% | – |
| Operating margin | -12,343.6% | – |
| Net margin | -11,276.5% | – |
| Return on equity | -35.6% | -25.9% |
| Analyst target vs. price | +1.0% | +111.3% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 78 | 51 |
| 30-day volatility | 239.6% | 62.3% |
| Max drawdown, 1 year | -43.7% | -40.6% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- AVLN is the largest of the group by market value.
- AVLN has been the calmest stock over the last 30 days.